These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 23188647)

  • 1. Flavonoids and polymer derivatives as CYP3A4 inhibitors for improved oral drug bioavailability.
    Fasinu P; Choonara YE; Khan RA; Du Toit LC; Kumar P; Ndesendo VM; Pillay V
    J Pharm Sci; 2013 Feb; 102(2):541-55. PubMed ID: 23188647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of the Oral Bioavailability of Felodipine Employing 8-Arm-Poly(Ethylene Glycol): In Vivo, In Vitro and In Silico Evaluation.
    Fasinu P; Choonara YE; Kumar P; du Toit LC; Bijukumar D; Khan RA; Pillay V
    AAPS PharmSciTech; 2017 Apr; 18(3):617-628. PubMed ID: 27173987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thiomers: Inhibition of cytochrome P450 activity.
    Iqbal J; Sakloetsakun D; Bernkop-Schnürch A
    Eur J Pharm Biopharm; 2011 Aug; 78(3):361-5. PubMed ID: 21362475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of peppermint oil and ascorbyl palmitate as inhibitors of cytochrome P4503A4 activity in vitro and in vivo.
    Dresser GK; Wacher V; Wong S; Wong HT; Bailey DG
    Clin Pharmacol Ther; 2002 Sep; 72(3):247-55. PubMed ID: 12235445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug interaction study of flavonoids toward CYP3A4 and their quantitative structure activity relationship (QSAR) analysis for predicting potential effects.
    Li Y; Ning J; Wang Y; Wang C; Sun C; Huo X; Yu Z; Feng L; Zhang B; Tian X; Ma X
    Toxicol Lett; 2018 Sep; 294():27-36. PubMed ID: 29753067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of time-dependent inactivation of CYP3A4 in cryopreserved human hepatocytes and assessment of human drug-drug interactions.
    Chen Y; Liu L; Monshouwer M; Fretland AJ
    Drug Metab Dispos; 2011 Nov; 39(11):2085-92. PubMed ID: 21835977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of transgenic mouse models to understand the oral disposition and drug-drug interaction potential of cobimetinib, a MEK inhibitor.
    Choo EF; Woolsey S; DeMent K; Ly J; Messick K; Qin A; Takahashi R
    Drug Metab Dispos; 2015 Jun; 43(6):864-9. PubMed ID: 25813936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of human drug-drug interactions from time-dependent inactivation of CYP3A4 in primary hepatocytes using a population-based simulator.
    Xu L; Chen Y; Pan Y; Skiles GL; Shou M
    Drug Metab Dispos; 2009 Dec; 37(12):2330-9. PubMed ID: 19773538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of CYP3A4 and CYP2D6 Interactions of Withania somnifera and Centella asiatica in Human Liver Microsomes.
    Savai J; Varghese A; Pandita N; Chintamaneni M
    Phytother Res; 2015 May; 29(5):785-90. PubMed ID: 25684704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition and stimulation of intestinal and hepatic CYP3A activity: studies in humanized CYP3A4 transgenic mice using triazolam.
    van Waterschoot RA; Rooswinkel RW; Sparidans RW; van Herwaarden AE; Beijnen JH; Schinkel AH
    Drug Metab Dispos; 2009 Dec; 37(12):2305-13. PubMed ID: 19752211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of myricetin on the bioavailability of doxorubicin for oral drug delivery in rats: possible role of CYP3A4 and P-glycoprotein inhibition by myricetin.
    Choi SJ; Shin SC; Choi JS
    Arch Pharm Res; 2011 Feb; 34(2):309-15. PubMed ID: 21380815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of human CYP3A4 activity by grapefruit flavonoids, furanocoumarins and related compounds.
    Ho PC; Saville DJ; Wanwimolruk S
    J Pharm Pharm Sci; 2001; 4(3):217-27. PubMed ID: 11737987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of novel substrates for human cytochrome P450 2J2.
    Lee CA; Neul D; Clouser-Roche A; Dalvie D; Wester MR; Jiang Y; Jones JP; Freiwald S; Zientek M; Totah RA
    Drug Metab Dispos; 2010 Feb; 38(2):347-56. PubMed ID: 19923256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced oral bioavailability of felodipine by naringenin in Wistar rats and inhibition of P-glycoprotein in everted rat gut sacs in vitro.
    Surya Sandeep M; Sridhar V; Puneeth Y; Ravindra Babu P; Naveen Babu K
    Drug Dev Ind Pharm; 2014 Oct; 40(10):1371-7. PubMed ID: 23883365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potent inhibition of human cytochrome P450 3A isoforms by cannabidiol: role of phenolic hydroxyl groups in the resorcinol moiety.
    Yamaori S; Ebisawa J; Okushima Y; Yamamoto I; Watanabe K
    Life Sci; 2011 Apr; 88(15-16):730-6. PubMed ID: 21356216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polysaccharide peptides from Coriolus versicolor competitively inhibit model cytochrome P450 enzyme probe substrates metabolism in human liver microsomes.
    Yeung JH; Or PM
    Phytomedicine; 2012 Mar; 19(5):457-63. PubMed ID: 22305191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P-glycoprotein and cytochrome P450 3A act together in restricting the oral bioavailability of paclitaxel.
    Hendrikx JJ; Lagas JS; Rosing H; Schellens JH; Beijnen JH; Schinkel AH
    Int J Cancer; 2013 May; 132(10):2439-47. PubMed ID: 23090875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of crizotinib-midazolam interaction using the Simcyp population-based simulator: comparison of CYP3A time-dependent inhibition between human liver microsomes versus hepatocytes.
    Mao J; Johnson TR; Shen Z; Yamazaki S
    Drug Metab Dispos; 2013 Feb; 41(2):343-52. PubMed ID: 23129213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene Polymorphisms and Drug-Drug Interactions Determine the Metabolic Profile of Blonanserin.
    Ye F; Li X; Ni J; Xu X; Luo J; Zhong Y; Wang Y; Wang S; Zhang Y; Hu G; Qian J
    J Pharmacol Exp Ther; 2024 Jan; 388(1):190-200. PubMed ID: 37863485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Flavonoids in Lysimachia clethroides Duby on the Activities of Cytochrome P450 CYP2E1 and CYP3A4 in Rat Liver Microsomes.
    Zhang ZJ; Xia ZY; Wang JM; Song XT; Wei JF; Kang WY
    Molecules; 2016 Jun; 21(6):. PubMed ID: 27314315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.